Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke [Clinical Sciences]

Conclusions— Desmoteplase in both 70 and 90 μg/kg doses had a favorable safety profile and was well tolerated in Japanese patients with acute ischemic stroke when administered 3 to 9 hours after stroke symptoms onset. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT01104467.

http://stroke.ahajournals.org/cgi/content/short/46/9/2549?rss=1

Source: Stroke - August 24, 2015 Category: Neurology Authors: Mori, E., Minematsu, K., Nakagawara, J., Hasegawa, Y., Nagahiro, S., Okada, Y., Truelsen, T., Lindsten, A., Ogawa, A., Yamaguchi, T., on behalf of DIAS-J Investigators Tags: Acute Cerebral Infarction, Acute Stroke Syndromes, Thrombolysis Clinical Sciences Source Type: research